Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Adults with Moderate-to-Severe Plaque Psoriasis
.
Show all posts
Showing posts with label
Adults with Moderate-to-Severe Plaque Psoriasis
.
Show all posts
Monday, September 26, 2022
FDA Approves Sotyktu (deucravacitinib) for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis
›
Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval of Sotyktu ™ (deucravacitinib), a fi...
›
Home
View web version
